It has been reported that MPS1 was predominantly expressed in human breast tumors and activated by the loss of function mutation of TP53, which is also known as the main determinant of tumorigenesis in EC (Győrffy et al., 2014). This evidence concerns the gene TP53 and breast neoplasm.